Literature DB >> 11172214

Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.

J H Lee1, M Machtay, M G McKenna, G S Weinstein, D A Markiewicz, R E Krisch, M M Kligerman.   

Abstract

PURPOSE: Radiation therapy has a high success rate in the treatment of early glottic carcinoma. Excellent outcomes have been reported from centers using cobalt-60 or relatively low-energy (< or = 4 MV) radiation therapy to achieve these results. Whether similar outcomes can be achieved with a 6 MV linear accelerator has been less rigorously evaluated. This study assesses the efficacy of 6 MV radiation therapy for early stage glottic cancer and identifies prognostic factors for local control and overall survival in this common disease.
MATERIALS AND METHODS: One hundred twenty-eight consecutive cases of Tis, T1, and T2 squamous cell carcinomas of the glottis from 1982 to 1996 were retrospectively analyzed with regard to local control and survival. All patients were treated with definitive radiation therapy with a 6-MV linear accelerator. Potential prognostic factors for local control and survival were evaluated with univariate and multivariate models. Median follow-up of locally controlled patients was 65 months.
RESULTS: The overall 3-year actuarial local control rates for T1 and T2 carcinomas were 86% and 68%, respectively. Patients with lesions involving the posterior third of the vocal cord had significantly worse 3-year local control (76% vs. 86%, P =.038). Radiation therapy technique and overall treatment time did not significantly affect local control. For patients with Tis and T1 lesions, factors associated with significantly worse local control included cordectomy-ineligible disease (P =.024), dose less than 6,600 cGy (P =.024), and lesions limited to the posterior third of the vocal cord (P =.004). Three-year local control was 76%, with doses less than 6,600 cGy and 90% with higher doses. High rates of second primary malignancies were observed and represented the major cause of death. Five-year overall survival was 84%.
CONCLUSIONS: The use of 6-MV photons for treatment of early glottic cancer seems to achieve local control similar to that reported with lower-energy photons. However, patients with posterior third involvement had a poorer local control rate with standard radiation therapy, thereby suggesting that alternative approaches be considered.

Entities:  

Mesh:

Year:  2001        PMID: 11172214     DOI: 10.1053/ajot.2001.20679

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  8 in total

Review 1.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

Review 2.  Second primary tumors in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Emanuel Celice Castilho; Luiz Paulo Kowalski
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

3.  Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Jefferson Luiz Gross; Claudia Zitron Sztokfisz; Inês Nobuko Nishimoto; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-18       Impact factor: 2.503

4.  Definitive radiotherapy for early stage glottic cancer by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger Kai-Cheong Ngan; Foon-Yiu Cheung; Sin-Ming Chow; Yiu-Tung Fu; Joseph Siu-Kei Au; Stephen Chun-Key Law
Journal:  Head Neck Oncol       Date:  2012-05-18

5.  Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger K C Ngan; Sin-Ming Chow; Foon-Yiu Cheung; Yiu-Tung Fu; Joseph S K Au; Stephen C K Law
Journal:  Radiat Oncol       Date:  2011-05-21       Impact factor: 3.481

6.  TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors.

Authors:  Marianna Marconato Rettori; Ana Carolina de Carvalho; Ana Luiza Bomfim Longo; Cleyton Zanardo de Oliveira; Luiz Paulo Kowalski; André Lopes Carvalho; André Luiz Vettore
Journal:  J Transl Med       Date:  2013-12-20       Impact factor: 5.531

7.  Three-week hypofractionated radiotherapy in early glottic cancer-a single institution retrospective study.

Authors:  Arun Sankar Sudha; Ravikumar Rejnish Kumar; Milan Anjanappa; Cessal Thomas Kainickal; Aleyamma Mathew; Ramadas Kunnambath
Journal:  Ecancermedicalscience       Date:  2022-05-04

8.  The thyro-cricoarytenoid space (TCAS): clinical and prognostic implications in laryngeal cancer.

Authors:  Marco Lucioni; Marco Lionello; Francesco Guida; Federica Sovran; Fabio Canal; Giuseppe Rizzotto; Andy Bertolin
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.